The NetworkNewsAudio News Podcast

NetworkNewsWire Editorial Coverage: Already proven to be a revolutionary treatment for type 2 diabetes and weight loss, glucagon-like peptide-1 (GLP-1) agonists now appear to have a multitude of potential blockbuster therapeutic uses, according to recent research. Obviously, diabetes remains a primary indication, given the massive global need. However, the impact of this extraordinary molecule extends far beyond type 2 diabetes. The reach of GLP-1 drugs has widened in ways its inventors likely never imagined. Clinical trials are underway testing GLP-1 drugs to treat Alzheimer's, Parkinson's, and even drug addiction, plus there are strong indications of therapeutic efficacy in heart disease and chronic kidney disease, as well as a wide range of other conditions, including weight loss. The newfound applications of this super-drug re-enforce both the reach and impact of Lexaria Bioscience Corp. (NASDAQ: LEXX) (Profile). By supercharging GLP-1 drugs with its DehydraTECH(TM) drug-delivery formulation and processing technology, Lexaria intends to improve both delivery and efficacy of GLP-1 for diabetes and potentially a host of other maladies. With several key studies on the near-term horizon, Lexaria has positioned itself in the midst of these market opportunities alongside others changing the landscape, such as Pfizer Inc. (NYSE: PFE), Merck & Company Inc. (NYSE: MRK), AstraZeneca PLC (NASDAQ: AZN) and Novo Nordisk (NYSE: NVO). GLP-1 agonists are the hottest drugs in healthcare today, with uses targeting multibillion-dollar diabetes and obesity markets and much more. Lexaria Bioscience is utilizing its patented DehydraTECH drug-delivery platform to improve the way active molecules enter the bloodstream upon oral ingestion. A pilot study showed that a DehydraTECH-processed form of blockbuster Rybelsus (a GLP-1) was more effective controlling blood glucose than standard Rybelsus. Lexaria recently received final data from the study and plans to conduct additional human studies during Q1 2024. Click here to view the custom infographic of the Lexaria Bioscience Corp. editorial.

NetworkNewsWire Editorial Coverage: Already proven to be a revolutionary treatment for type 2 diabetes and weight loss, glucagon-like peptide-1 (GLP-1) agonists now appear to have a multitude of potential blockbuster therapeutic uses, according to recent research. Obviously, diabetes remains a primary indication, given the massive global need. However, the impact of this extraordinary molecule extends far beyond type 2 diabetes. The reach of GLP-1 drugs has widened in ways its inventors likely never imagined. Clinical trials are underway testing GLP-1 drugs to treat Alzheimer's, Parkinson's, and even drug addiction, plus there are strong indications of therapeutic efficacy in heart disease and chronic kidney disease, as well as a wide range of other conditions, including weight loss. The newfound applications of this super-drug re-enforce both the reach and impact of Lexaria Bioscience Corp. (NASDAQ: LEXX) (Profile). By supercharging GLP-1 drugs with its DehydraTECH(TM) drug-delivery formulation and processing technology, Lexaria intends to improve both delivery and efficacy of GLP-1 for diabetes and potentially a host of other maladies. With several key studies on the near-term horizon, Lexaria has positioned itself in the midst of these market opportunities alongside others changing the landscape, such as Pfizer Inc. (NYSE: PFE), Merck & Company Inc. (NYSE: MRK), AstraZeneca PLC (NASDAQ: AZN) and Novo Nordisk (NYSE: NVO). GLP-1 agonists are the hottest drugs in healthcare today, with uses targeting multibillion-dollar diabetes and obesity markets and much more. Lexaria Bioscience is utilizing its patented DehydraTECH drug-delivery platform to improve the way active molecules enter the bloodstream upon oral ingestion. A pilot study showed that a DehydraTECH-processed form of blockbuster Rybelsus (a GLP-1) was more effective controlling blood glucose than standard Rybelsus. Lexaria recently received final data from the study and plans to conduct additional human studies during Q1 2024. Click here to view the custom infographic of the Lexaria Bioscience Corp. editorial.

CNS Pharmaceuticals (NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, recently announced the recommendation of the independent Data Safety Monitoring Board (DSMB) that the Company's ongoing global, potentially pivotal trial of the investigational agent, Berubicin for the treatment of glioblastoma multiforme (GBM) continue without any modification. The recommendation follows the DSMB's pre-specified futility analysis of unblinded (to the DSMB only) efficacy and safety data in the Company's trial of Berubicin versus Lomustine, a standard of care in patients with recurrent GBM. More specifically, the DSMB reviewed the primary endpoint of overall survival (OS) and secondary efficacy measures progression-free survival (PFF) and overall response rate (ORR), as well as safety data in evaluable patients. In order to support continuing the trial, Berubicin's efficacy had to be at least comparable to Lomustine's on the primary endpoint (OS). To read the original press release, visit: https://www.nnw.fm/Sj7iP Please see full terms of use and disclaimers on the IBN website applicable to all content provided by IBN, wherever published or re-published: https://IBN.fm/Disclaimer  

CNS Pharmaceuticals (NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, recently announced the recommendation of the independent Data Safety Monitoring Board (DSMB) that the Company's ongoing global, potentially pivotal trial of the investigational agent, Berubicin for the treatment of glioblastoma multiforme (GBM) continue without any modification. The recommendation follows the DSMB's pre-specified futility analysis of unblinded (to the DSMB only) efficacy and safety data in the Company's trial of Berubicin versus Lomustine, a standard of care in patients with recurrent GBM. More specifically, the DSMB reviewed the primary endpoint of overall survival (OS) and secondary efficacy measures progression-free survival (PFF) and overall response rate (ORR), as well as safety data in evaluable patients. In order to support continuing the trial, Berubicin's efficacy had to be at least comparable to Lomustine's on the primary endpoint (OS). To read the original press release, visit: https://www.nnw.fm/Sj7iP Please see full terms of use and disclaimers on the IBN website applicable to all content provided by IBN, wherever published or re-published: https://IBN.fm/Disclaimer  

NetworkNewsWire Editorial Coverage: The prestigious New England Journal of Medicine recently published results of a large study of 2,539 adults wherein weight loss of 49 to 52 pounds was a common outcome. With more than 37 million Americans suffering from diabetes, and with obesity at epidemic levels, it's little wonder that millions of people are singing their praises of the new class of drugs responsible for these outrageously positive outcomes. GLP-1 agonists are a class of medications that mainly help manage blood sugar (glucose) levels in people with type 2 diabetes but are also helping treat obesity. Seems everyone is excited about controlling blood sugar and easily losing weight. But there may be an even better avenue to increased effectiveness and better outcomes. Lexaria Bioscience Corp. (NASDAQ: LEXX) (Profile), a global innovator in drug-delivery platforms, began diabetes-related formal studies last year with its DehydraTECH(TM) platform, which showed reduced blood-sugar levels and lowered body weight. With such encouraging early results, Lexaria is planning to launch new human and animal studies to examine whether DehydraTECH processing can make GLP-1 drugs such as semaglutide even better. Lexaria's heavily-patented DehydraTECH drug delivery technology might  improve bioavailability, lower costs, and enhance tolerability, weight-loss potential and management of diabetes and other health conditions. DehydraTECH may become a game changer in the multibillion-dollar GLP-1 drug market and could potentially lead to a collaboration with a dominant player in the space, such as Novo Nordisk (NYSE: NVO, Pfizer Inc. (NYSE: PFE), Merck & Company Inc. (NYSE: MRK), or AstraZeneca PLC (NASDAQ: AZN). Lexaria's DehydraTECH is easily integrated into oral product manufacturing processes to better deliver API payloads to improve bioavailability, reduce side effects and more. Lexaria is evaluating the impact of DehydraTECH on oral performance of GLP-1 drugs for diabetes and weight loss, a market forecast to reach up to an astonishing $200 billion per year. DehydraTECH is a scalable technology for a multitude of applications that has separately been licensed by Altria for oral nicotine products. DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

NetworkNewsWire Editorial Coverage: The prestigious New England Journal of Medicine recently published results of a large study of 2,539 adults wherein weight loss of 49 to 52 pounds was a common outcome. With more than 37 million Americans suffering from diabetes, and with obesity at epidemic levels, it's little wonder that millions of people are singing their praises of the new class of drugs responsible for these outrageously positive outcomes. GLP-1 agonists are a class of medications that mainly help manage blood sugar (glucose) levels in people with type 2 diabetes but are also helping treat obesity. Seems everyone is excited about controlling blood sugar and easily losing weight. But there may be an even better avenue to increased effectiveness and better outcomes. Lexaria Bioscience Corp. (NASDAQ: LEXX) (Profile), a global innovator in drug-delivery platforms, began diabetes-related formal studies last year with its DehydraTECH(TM) platform, which showed reduced blood-sugar levels and lowered body weight. With such encouraging early results, Lexaria is planning to launch new human and animal studies to examine whether DehydraTECH processing can make GLP-1 drugs such as semaglutide even better. Lexaria's heavily-patented DehydraTECH drug delivery technology might  improve bioavailability, lower costs, and enhance tolerability, weight-loss potential and management of diabetes and other health conditions. DehydraTECH may become a game changer in the multibillion-dollar GLP-1 drug market and could potentially lead to a collaboration with a dominant player in the space, such as Novo Nordisk (NYSE: NVO, Pfizer Inc. (NYSE: PFE), Merck & Company Inc. (NYSE: MRK), or AstraZeneca PLC (NASDAQ: AZN). Lexaria's DehydraTECH is easily integrated into oral product manufacturing processes to better deliver API payloads to improve bioavailability, reduce side effects and more. Lexaria is evaluating the impact of DehydraTECH on oral performance of GLP-1 drugs for diabetes and weight loss, a market forecast to reach up to an astonishing $200 billion per year. DehydraTECH is a scalable technology for a multitude of applications that has separately been licensed by Altria for oral nicotine products. DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers Longeveron's recent announcement of positive top-line results from its Phase 2a trial of its investigational product Lomecel-B™ for the treatment of mild Alzheimer's disease. “We believe these results provide important validation of both the safety and therapeutic potential of Lomecel-B™ in the treatment of Alzheimer's disease and provide a robust foundation for additional clinical trials in this and other indications,” Wa'el Hashad, CEO of Longeveron, stated in the news release. “We look forward to announcing additional biomarker data from this trial, anticipated to be later this month, which may further characterize the clinical effects of Lomecel-B™ in this study population. With our Phase 2 ELPIS II trial in HLHS moving toward anticipated completion in 2024, and our Phase 2 program in Aging-related Frailty progressing in Japan as well, we look forward to meaningful milestones in the near term and to fully realizing the therapeutic potential of Lomecel-B™.” To read the original press release, visit: https://nnw.fm/ckhHp Please see full terms of use and disclaimers on the IBN website applicable to all content provided by IBN, wherever published or re-published: https://IBN.fm/Disclaimer

Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers Longeveron's recent announcement of positive top-line results from its Phase 2a trial of its investigational product Lomecel-B™ for the treatment of mild Alzheimer's disease. “We believe these results provide important validation of both the safety and therapeutic potential of Lomecel-B™ in the treatment of Alzheimer's disease and provide a robust foundation for additional clinical trials in this and other indications,” Wa'el Hashad, CEO of Longeveron, stated in the news release. “We look forward to announcing additional biomarker data from this trial, anticipated to be later this month, which may further characterize the clinical effects of Lomecel-B™ in this study population. With our Phase 2 ELPIS II trial in HLHS moving toward anticipated completion in 2024, and our Phase 2 program in Aging-related Frailty progressing in Japan as well, we look forward to meaningful milestones in the near term and to fully realizing the therapeutic potential of Lomecel-B™.” To read the original press release, visit: https://nnw.fm/ckhHp Please see full terms of use and disclaimers on the IBN website applicable to all content provided by IBN, wherever published or re-published: https://IBN.fm/Disclaimer

In volatile economic conditions, smart money seeks stability and moves to safe havens. Historically, one of the safest places and most stable spaces during economic uncertainty is gold, a highly liquid asset that preserves and even increases in value over time and carries no credit risk. The precious metal benefits from multiple levers of demand such as gold jewelry, tech/industrial use and a reserve asset as well as a strategic investment. History has shown that gold's variable demand pressures enhance a portfolio by improving diversification, providing liquidity and delivering long-term returns. Reacting to uncertainties, many gold mining companies, including GEMXX Corp. (OTC: GEMZ) (profile), have enjoyed significant growth during the recent volatility. Exploding past startup phase and achieving global growth in mere months, GEMXX is fast approaching a holy grail that differentiates GEMXX from all others in the gold space – a vertically integrated mining company – a unique mine-to-market enterprise that specializes in gold and gemstone mining as well as jewelry creation, production and global sales. GEMXX owns and controls every aspect of the process from gold mining and gemstone finishing to jewelry manufacturing and global distribution. Other larger mining companies may not have the unique vertical integration of GEMXX but are still seeing success in the precious metal sector including Agnico Eagle Mines Ltd. (NYSE: AEM), which recently reported record second-quarter numbers; Barrick Gold (NYSE: GOLD), which anticipates a second half of the year performance that surpasses its first; Newmont Mining (NYSE: NEM), which has received required approvals on a key acquisition announced earlier this year; and Franco-Nevada Corp. (NYSE: FNV), which has established a business model that provides investors with gold price and exploration optionality while limiting exposure to cost inflation. To view the full editorial, visit https://ibn.fm/trQPF

In volatile economic conditions, smart money seeks stability and moves to safe havens. Historically, one of the safest places and most stable spaces during economic uncertainty is gold, a highly liquid asset that preserves and even increases in value over time and carries no credit risk. The precious metal benefits from multiple levers of demand such as gold jewelry, tech/industrial use and a reserve asset as well as a strategic investment. History has shown that gold's variable demand pressures enhance a portfolio by improving diversification, providing liquidity and delivering long-term returns. Reacting to uncertainties, many gold mining companies, including GEMXX Corp. (OTC: GEMZ) (profile), have enjoyed significant growth during the recent volatility. Exploding past startup phase and achieving global growth in mere months, GEMXX is fast approaching a holy grail that differentiates GEMXX from all others in the gold space – a vertically integrated mining company – a unique mine-to-market enterprise that specializes in gold and gemstone mining as well as jewelry creation, production and global sales. GEMXX owns and controls every aspect of the process from gold mining and gemstone finishing to jewelry manufacturing and global distribution. Other larger mining companies may not have the unique vertical integration of GEMXX but are still seeing success in the precious metal sector including Agnico Eagle Mines Ltd. (NYSE: AEM), which recently reported record second-quarter numbers; Barrick Gold (NYSE: GOLD), which anticipates a second half of the year performance that surpasses its first; Newmont Mining (NYSE: NEM), which has received required approvals on a key acquisition announced earlier this year; and Franco-Nevada Corp. (NYSE: FNV), which has established a business model that provides investors with gold price and exploration optionality while limiting exposure to cost inflation. To view the full editorial, visit https://ibn.fm/trQPF  

In the business world, one of the cardinal reasons for mergers and acquisitions (M&As) is the potential for synergistic growth. Successful companies usually measure this in terms of revenue streams, market share and product offerings. However, in the age of digital technology and globalization, a significant facet of growth potential is often found a company's core customer base and digital reputation. Lucy Scientific Discovery (NASDAQ: LSDI) (Profile) is astutely following this road map utilized by hugely successful corporations by uniquely leveraging user bases to rapidly amplify shareholder value. This well-established, albeit counterintuitive, M&A strategy has been utilized by several major companies including Meta Platforms Inc. (NASDAQ: META), Microsoft Corp. (NASDAQ: MSFT), Amazon.com Inc. (NASDAQ: AMZN) and Apple Inc. (NASDAQ: AAPL) with the unconventional process producing results that vastly exceeded expected typical M&A metrics. To view the full editorial, visit https://nnw.fm/vNVcN  

In the business world, one of the cardinal reasons for mergers and acquisitions (M&As) is the potential for synergistic growth. Successful companies usually measure this in terms of revenue streams, market share and product offerings. However, in the age of digital technology and globalization, a significant facet of growth potential is often found a company's core customer base and digital reputation. Lucy Scientific Discovery (NASDAQ: LSDI) (Profile) is astutely following this road map utilized by hugely successful corporations by uniquely leveraging user bases to rapidly amplify shareholder value. This well-established, albeit counterintuitive, M&A strategy has been utilized by several major companies including Meta Platforms Inc. (NASDAQ: META), Microsoft Corp. (NASDAQ: MSFT), Amazon.com Inc. (NASDAQ: AMZN) and Apple Inc. (NASDAQ: AAPL) with the unconventional process producing results that vastly exceeded expected typical M&A metrics. To view the full editorial, visit https://nnw.fm/vNVcN

Knightscope, Inc. (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers Knightscope’s recent announcement that Ascendiant Capital Markets LLC (“Ascendiant”) has initiated coverage on the company’s stock with a buy rating and a price target of $3.50 per share. “This recognition from Ascendiant reflects their confidence in our innovative autonomous security solutions, our strong market position and our ability to deliver long-term value to our shareholders with a buy rating,” William Santana Li, chairman and CEO of Knightscope, stated in the news release. “The Rise of the Robots continues, and Wall Street is now taking notice that Knightscope has a unique set of disruptive technologies combining artificial intelligence, autonomy, robotics and electric vehicle technology.” To read the original press release, visit: https://nnw.fm/E15kA

Knightscope, Inc. (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers Knightscope's recent announcement that Ascendiant Capital Markets LLC (“Ascendiant”) has initiated coverage on the company's stock with a buy rating and a price target of $3.50 per share. “This recognition from Ascendiant reflects their confidence in our innovative autonomous security solutions, our strong market position and our ability to deliver long-term value to our shareholders with a buy rating,” William Santana Li, chairman and CEO of Knightscope, stated in the news release. “The Rise of the Robots continues, and Wall Street is now taking notice that Knightscope has a unique set of disruptive technologies combining artificial intelligence, autonomy, robotics and electric vehicle technology.” To read the original press release, visit: https://nnw.fm/E15kA

The transition from fossil fuels to electrification has created a huge increase in demand for rare earth oxides and demand is expected to get much larger. Rare earth oxides are irreplaceable elements integral to permanent magnets, critical components in electric vehicles and sustainable power generation equipment, especially windmills. About 90% of all permanent magnets are currently produced in China, which is now considering banning or restricting exports of technology to process and refine rare-earth elements. Beijing is also pondering provisions prohibiting or limiting exports of alloy technology used in making high performance magnets made from rare earths minerals. As the transition to a cleaner world grows, China is restricting exports of permanent magnets and related tech in favor of feeding domestic demand, thus strangling the global transition. Governments in North America and across the world have voiced extreme urgency in reshaping supply chains to reduce dependence upon China and achieve clean energy mandates. Only a few companies can be called leaders in a nascent yet potentially explosive market. Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) (Profile) stands out with its transformative technology, RapidSX(TM), for separating and purifying critical metals. Also in the hunt for market share in this burgeoning new market is MP Materials Corp. (NYSE: MP), Neo Performance Materials Inc. (TSX: NEO), Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) and Li-Cycle Holdings Corp. (NYSE: LICY), all of which have established footholds and expanding operations in a concerted effort to shift away from reliance upon China and achieve energy independence. To view the full editorial, visit https://nnw.fm/v5C04

The transition from fossil fuels to electrification has created a huge increase in demand for rare earth oxides and demand is expected to get much larger. Rare earth oxides are irreplaceable elements integral to permanent magnets, critical components in electric vehicles and sustainable power generation equipment, especially windmills. About 90% of all permanent magnets are currently produced in China, which is now considering banning or restricting exports of technology to process and refine rare-earth elements. Beijing is also pondering provisions prohibiting or limiting exports of alloy technology used in making high performance magnets made from rare earths minerals. As the transition to a cleaner world grows, China is restricting exports of permanent magnets and related tech in favor of feeding domestic demand, thus strangling the global transition. Governments in North America and across the world have voiced extreme urgency in reshaping supply chains to reduce dependence upon China and achieve clean energy mandates. Only a few companies can be called leaders in a nascent yet potentially explosive market. Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) (Profile) stands out with its transformative technology, RapidSX(TM), for separating and purifying critical metals. Also in the hunt for market share in this burgeoning new market is MP Materials Corp. (NYSE: MP), Neo Performance Materials Inc. (TSX: NEO), Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) and Li-Cycle Holdings Corp. (NYSE: LICY), all of which have established footholds and expanding operations in a concerted effort to shift away from reliance upon China and achieve energy independence. To view the full editorial, visit https://nnw.fm/v5C04  

Slave Lake Zinc (CSE: SLZ) (the “Company”) has reviewed historic drill logs recently obtained for 13 drill holes reported by American Yellowknife Mines from drilling conducted in 1951 at the MCO targets on the west side of O'Connor Lake. Slave Lake has noted that pegmatites and pegmatitic granites have been documented in these holes. Pegmatites were reported and ranged from less than 1 meter to over 10 meters in drill section. Exploration in 1951 was designed to test for zinc-lead-copper mineralization at O'Connor Lake. There was no evaluation for lithium or tantalum-columbite mineralization which are now a necessity for electrification (green energy). To view the full press release, visit https://nnw.fm/D2hyq

Slave Lake Zinc (CSE: SLZ) (the “Company”) has reviewed historic drill logs recently obtained for 13 drill holes reported by American Yellowknife Mines from drilling conducted in 1951 at the MCO targets on the west side of O'Connor Lake. Slave Lake has noted that pegmatites and pegmatitic granites have been documented in these holes. Pegmatites were reported and ranged from less than 1 meter to over 10 meters in drill section. Exploration in 1951 was designed to test for zinc-lead-copper mineralization at O'Connor Lake. There was no evaluation for lithium or tantalum-columbite mineralization which are now a necessity for electrification (green energy). To view the full press release, visit https://nnw.fm/D2hyq  

Sostravel.com S.p.A. (BIT: SOS) (OTCQB: SOSAF) announced its business plan following the release of strong financial results for 2022.   To read the original press release, visit: https://ibn.fm/XeRsq   “Sostravel.com offers investors a unique opportunity to gain exposure to global travel and digital travel services growth,” Edoardo Zarghetta, IR Advisor for Sostravel.com, stated in the news release. “Our robust financial profile with a strong track record of profitability and operating cash flow generation, combined with flexible cost structure, commitment to preserving cash and balancing cost controls with investments, is already catching investors' attention.”   Sostravel.com announced a positive EBITDA margin in 2022 attained in a year where revenues grew by 47%. Based on these positive results, the company unveiled its business plan, detailing the strategy behind the doubling of revenues and the 173x EBITDA growth expected by 2027.   As explained in the news release, Sostravel.com intends to bolster its recent growth by selling high-margin, private-label offerings of digital travel to Sardinia, the Red Sea and Kenya via both internal and major third-party booking platforms. It also plans to expand its ‘Secret Village' offering in Sardinia, which proved popular with travelers, and promote growth of its Lost Luggage Concierge services aimed at the protection and recovery of air passengers' luggage. Finally, Sostravel.com aims to launch a traveler-centered telehealth solution via the sostravel app to better meet the needs of international tourists.    

Sostravel.com S.p.A. (BIT: SOS) (OTCQB: SOSAF) announced its business plan following the release of strong financial results for 2022.   To read the original press release, visit: https://ibn.fm/XeRsq   “Sostravel.com offers investors a unique opportunity to gain exposure to global travel and digital travel services growth,” Edoardo Zarghetta, IR Advisor for Sostravel.com, stated in the news release. “Our robust financial profile with a strong track record of profitability and operating cash flow generation, combined with flexible cost structure, commitment to preserving cash and balancing cost controls with investments, is already catching investors' attention.”   Sostravel.com announced a positive EBITDA margin in 2022 attained in a year where revenues grew by 47%. Based on these positive results, the company unveiled its business plan, detailing the strategy behind the doubling of revenues and the 173x EBITDA growth expected by 2027.   As explained in the news release, Sostravel.com intends to bolster its recent growth by selling high-margin, private-label offerings of digital travel to Sardinia, the Red Sea and Kenya via both internal and major third-party booking platforms. It also plans to expand its ‘Secret Village' offering in Sardinia, which proved popular with travelers, and promote growth of its Lost Luggage Concierge services aimed at the protection and recovery of air passengers' luggage. Finally, Sostravel.com aims to launch a traveler-centered telehealth solution via the sostravel app to better meet the needs of international tourists.  

The market for renewable energy enjoys considerable tailwinds due to growing concerns about climate change, energy security and global initiatives to reign in carbon emissions. The tailwinds turned into a tempest late in 2022 when the Inflation Reduction Act (“IRA”) was signed into law. The IRA is the largest investment ever by the U.S. government in renewable energies, earmarking $369 billion to accelerate efforts to reduce dependence on fossil fuels. According to some experts, the IRA is expected to more than triple America's clean-energy production by 2030, resulting in about 40% of the nation's energy coming from sources such as wind, solar and renewable natural gas (“RNG”). For this to happen, about 550 gigawatts of new energy supply from green sources will come online over the next seven years. Against the backdrop of this generational opportunity, EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) (Profile), a specialist in RNG, has positioned itself as an emerging leader in the booming renewables sector. Others in the space that are recognized as leaders include oil juggernaut BP plc (NYSE: BP), utility Fortis Inc. (NYSE: FTS), cleantech 374Water Inc. (NASDAQ: SCWO) and Anaergia Inc. (TSX: ANRG).  

The market for renewable energy enjoys considerable tailwinds due to growing concerns about climate change, energy security and global initiatives to reign in carbon emissions. The tailwinds turned into a tempest late in 2022 when the Inflation Reduction Act (“IRA”) was signed into law. The IRA is the largest investment ever by the U.S. government in renewable energies, earmarking $369 billion to accelerate efforts to reduce dependence on fossil fuels. According to some experts, the IRA is expected to more than triple America's clean-energy production by 2030, resulting in about 40% of the nation's energy coming from sources such as wind, solar and renewable natural gas (“RNG”). For this to happen, about 550 gigawatts of new energy supply from green sources will come online over the next seven years. Against the backdrop of this generational opportunity, EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) (Profile), a specialist in RNG, has positioned itself as an emerging leader in the booming renewables sector. Others in the space that are recognized as leaders include oil juggernaut BP plc (NYSE: BP), utility Fortis Inc. (NYSE: FTS), cleantech 374Water Inc. (NASDAQ: SCWO) and Anaergia Inc. (TSX: ANRG).  

Knightscope, Inc. (NASDAQ: KSCP), a leading developer of autonomous security robots, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers Knightscope's recent securement of the largest single contract in the company's history alongside two new contracts from cities in New York and Georgia.  “Knightscope continues to deliver on its promise to rapidly grow the Company and help make the United States of America the safest country in the world,” William Santana Li, Chairman and CEO of Knightscope, stated in the news release from last week. “Today's announcement further supports my recent public address where we project tripling our annualized revenue over the next twelve months.”  To hear the audio production, visit: https://www.nnw.fm/FjVcX   To read the original press release, visit: https://nnw.fm/A9OK4 

Knightscope, Inc. (NASDAQ: KSCP), a leading developer of autonomous security robots, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers Knightscope's recent securement of the largest single contract in the company's history alongside two new contracts from cities in New York and Georgia.  “Knightscope continues to deliver on its promise to rapidly grow the Company and help make the United States of America the safest country in the world,” William Santana Li, Chairman and CEO of Knightscope, stated in the news release from last week. “Today's announcement further supports my recent public address where we project tripling our annualized revenue over the next twelve months.”  To hear the audio production, visit: https://www.nnw.fm/FjVcX   To read the original press release, visit: https://nnw.fm/A9OK4 

NetworkNewsWire Editorial Coverage: Although some people may be surprised, today's world is full of robots. While these electro-mechanical devices may not be in the form of a cyborg RoboCop, they're already serving people in countless ways. Industrial robots are a primary application today, with the world becoming accustomed to, and even expecting, life-altering technologies as robots shuttle people around, perform surgeries, keep communities safe, and much more. A global market summary by the International Federation of Robotics showed the robot trend accelerating, with a record 517,000 new industrial robots installed in factories around the world in 2021, up 31% from 2020. A host of innovative companies — including Knightscope, Inc. (NASDAQ: KSCP) (Profile), Velodyne Lidar Inc. (NASDAQ: VLDR), Pacific Gas & Electric Co. (NYSE: PCG), NVIDIA Corporation (NASDAQ: NVDA) and Palantir Technologies Inc. (NYSE: PLTR) — are investing in, developing and deploying leading-edge technology that is proving the value of robots in everyday lives or increasing their long-term potential.     Approximately 2.7 million industrial robots were in use in 2020, creating a global market valued at $55 billion that is expected to reach $165 billion by 2028.  Knightscope robots have 1.8-plus million hours of operation, have been documented to deter criminal activity and have proven invaluable in convictions of crimes.  Knightscope completed its first acquisition in October, buying CASE Emergency Systems.  November has seen a surge of new orders, activations for Knightscope crime-fighting robots and CASE emergency phones.    Click here to view the custom infographic of the Knightscope, Inc. editorial. 

NetworkNewsWire Editorial Coverage: Although some people may be surprised, today's world is full of robots. While these electro-mechanical devices may not be in the form of a cyborg RoboCop, they're already serving people in countless ways. Industrial robots are a primary application today, with the world becoming accustomed to, and even expecting, life-altering technologies as robots shuttle people around, perform surgeries, keep communities safe, and much more. A global market summary by the International Federation of Robotics showed the robot trend accelerating, with a record 517,000 new industrial robots installed in factories around the world in 2021, up 31% from 2020. A host of innovative companies — including Knightscope, Inc. (NASDAQ: KSCP) (Profile), Velodyne Lidar Inc. (NASDAQ: VLDR), Pacific Gas & Electric Co. (NYSE: PCG), NVIDIA Corporation (NASDAQ: NVDA) and Palantir Technologies Inc. (NYSE: PLTR) — are investing in, developing and deploying leading-edge technology that is proving the value of robots in everyday lives or increasing their long-term potential.     Approximately 2.7 million industrial robots were in use in 2020, creating a global market valued at $55 billion that is expected to reach $165 billion by 2028.  Knightscope robots have 1.8-plus million hours of operation, have been documented to deter criminal activity and have proven invaluable in convictions of crimes.  Knightscope completed its first acquisition in October, buying CASE Emergency Systems.  November has seen a surge of new orders, activations for Knightscope crime-fighting robots and CASE emergency phones.    Click here to view the custom infographic of the Knightscope, Inc. editorial. 

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers CNS Pharmaceuticals' recent announcement highlighting the activation of its first clinical trial sites in Europe for the ongoing potentially pivotal global trial evaluating Berubicin for the treatment of recurrent glioblastoma multiforme (GBM), one of the most aggressive types of brain cancer. To hear the audio production, visit: https://www.nnw.fm/TCHxT To read the original press release, visit: https://nnw.fm/js5dD “Our primary focus continues to be on advancing the clinical development of Berubicin as a potential treatment option for this devastating disease. Over the course of this year, we have worked diligently to expand patient eligibility for our potentially pivotal trial and bolster our international presence now realized with the activation of the first two European clinical trial sites,” John Climaco, CEO of CNS Pharmaceuticals, stated in the news release. “This is a true testament to our team's commitment to and the execution of this important clinical program.”

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers CNS Pharmaceuticals' recent announcement highlighting the activation of its first clinical trial sites in Europe for the ongoing potentially pivotal global trial evaluating Berubicin for the treatment of recurrent glioblastoma multiforme (GBM), one of the most aggressive types of brain cancer. To hear the audio production, visit: https://www.nnw.fm/TCHxT To read the original press release, visit: https://nnw.fm/js5dD “Our primary focus continues to be on advancing the clinical development of Berubicin as a potential treatment option for this devastating disease. Over the course of this year, we have worked diligently to expand patient eligibility for our potentially pivotal trial and bolster our international presence now realized with the activation of the first two European clinical trial sites,” John Climaco, CEO of CNS Pharmaceuticals, stated in the news release. “This is a true testament to our team's commitment to and the execution of this important clinical program.”

BlockQuarry Corp. (OTC: BLQC), a Texas-based company with commercial-stage operations in cryptocurrency mine hosting and self-mining in the Southeast United States, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers BlockQuarry's recent update on its provisional and unaudited Q3 performance projections, as well as highlights from its financial performance for the three months ended June 30, 2022.   To hear the audio production, visit: https://www.nnw.fm/nFqTT    To read the original press release, visit: https://www.nnw.fm/o2xvh    “We had a fantastic 2021, but we believe 2022 is on pace to significantly raise the bar,” Alonzo Pierce, President and Chair of BlockQuarry, stated in the news release. “Our hosting revenue this year has already surpassed what we produced from that segment for the whole year in 2021. Moreover, due to our market positioning and signed agreements with major partners, 2022 appears set to be our best year ever on both the top and bottom line, with Q3 on pace to show strong growth on both a sequential and year-over-year basis, and we are excited to further bolster our positioning and performance trajectory into year end.” 

BlockQuarry Corp. (OTC: BLQC), a Texas-based company with commercial-stage operations in cryptocurrency mine hosting and self-mining in the Southeast United States, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers BlockQuarry's recent update on its provisional and unaudited Q3 performance projections, as well as highlights from its financial performance for the three months ended June 30, 2022.   To hear the audio production, visit: https://www.nnw.fm/nFqTT    To read the original press release, visit: https://www.nnw.fm/o2xvh    “We had a fantastic 2021, but we believe 2022 is on pace to significantly raise the bar,” Alonzo Pierce, President and Chair of BlockQuarry, stated in the news release. “Our hosting revenue this year has already surpassed what we produced from that segment for the whole year in 2021. Moreover, due to our market positioning and signed agreements with major partners, 2022 appears set to be our best year ever on both the top and bottom line, with Q3 on pace to show strong growth on both a sequential and year-over-year basis, and we are excited to further bolster our positioning and performance trajectory into year end.” 

Quantum computing has moved from research to reality, as companies increasingly turn to the power of quantum mechanical effects to solve complex computational problems and maximize efficiencies throughout their businesses. When considering the quantum computing landscape, it's important to note that not all quantum computing technologies are the same and approaches vary. While some companies are focused on building quantum systems that won't be available for many years to come, others are offering real, practical quantum computing applications available today to help tackle a myriad of complex business challenges. Hundreds of early quantum applications have already been built to address complexities in resource scheduling, mobility, logistics, drug discovery, portfolio optimization, and manufacturing processes. Despite a growing marketplace of quantum computing players, only a handful are currently commercially viable. Industry pioneer D-Wave Quantum Inc. (NYSE: QBTS) (Profile) is the first company with real-world commercial annealing quantum computing services and the only company building both annealing and gate-based quantum computing products. D-Wave, which just became public via a SPAC merger, is at the vanguard of the quantum sea change in computing alongside other computer juggernauts such as Microsoft Corporation (NASDAQ: MSFT), Alphabet Inc. (NASDAQ: GOOGL), International Business Machines Corporation (NYSE: IBM) and Honeywell International Inc. (NASDAQ: HON).

Quantum computing has moved from research to reality, as companies increasingly turn to the power of quantum mechanical effects to solve complex computational problems and maximize efficiencies throughout their businesses. When considering the quantum computing landscape, it's important to note that not all quantum computing technologies are the same and approaches vary. While some companies are focused on building quantum systems that won't be available for many years to come, others are offering real, practical quantum computing applications available today to help tackle a myriad of complex business challenges. Hundreds of early quantum applications have already been built to address complexities in resource scheduling, mobility, logistics, drug discovery, portfolio optimization, and manufacturing processes. Despite a growing marketplace of quantum computing players, only a handful are currently commercially viable. Industry pioneer D-Wave Quantum Inc. (NYSE: QBTS) (Profile) is the first company with real-world commercial annealing quantum computing services and the only company building both annealing and gate-based quantum computing products. D-Wave, which just became public via a SPAC merger, is at the vanguard of the quantum sea change in computing alongside other computer juggernauts such as Microsoft Corporation (NASDAQ: MSFT), Alphabet Inc. (NASDAQ: GOOGL), International Business Machines Corporation (NYSE: IBM) and Honeywell International Inc. (NASDAQ: HON).

Nearly half of all American adults suffer from hypertension (high blood pressure), often referred to as a silent killer. More than 114 million adults in this country are at risk from damage caused by the long-term force of blood beating against artery walls, which often leads to disease and death. The good news is that hypertension is treatable and manageable through lifestyle changes and medications. Fact is, there are several approved blood pressure medications on the market, yet only about one in five people diagnosed with hypertension take medication. Why so few? Unfortunately, the side effects of these medications often outweigh the benefits. However, a new hypertension blockbuster may be imminent. A safer, better-tolerated drug candidate just marked a major milestone on the path to approval and commercialization. A global innovator in drug-delivery platforms, Lexaria Bioscience Corp. (NASDAQ: LEXX) (Profile) has been quietly progressing through clinical processes and amassing a growing body of evidence that strongly supports use of its patented DehydraTECH(TM) technology in hypertension therapeutics. The company's valuation looks attractive with arguably significant upside as it looks to rub shoulders and gain attention from the likes of Pfizer Inc. (NYSE: PFE), Merck & Company Inc. (NYSE: MRK), AstraZeneca PLC (NASDAQ: AZN) and Novartis AG (NYSE: NVS) — all aiming to capitalize on what may be the next blockbuster and defend hundreds of millions from a silent killer.

Nearly half of all American adults suffer from hypertension (high blood pressure), often referred to as a silent killer. More than 114 million adults in this country are at risk from damage caused by the long-term force of blood beating against artery walls, which often leads to disease and death. The good news is that hypertension is treatable and manageable through lifestyle changes and medications. Fact is, there are several approved blood pressure medications on the market, yet only about one in five people diagnosed with hypertension take medication. Why so few? Unfortunately, the side effects of these medications often outweigh the benefits. However, a new hypertension blockbuster may be imminent. A safer, better-tolerated drug candidate just marked a major milestone on the path to approval and commercialization. A global innovator in drug-delivery platforms, Lexaria Bioscience Corp. (NASDAQ: LEXX) (Profile) has been quietly progressing through clinical processes and amassing a growing body of evidence that strongly supports use of its patented DehydraTECH(TM) technology in hypertension therapeutics. The company's valuation looks attractive with arguably significant upside as it looks to rub shoulders and gain attention from the likes of Pfizer Inc. (NYSE: PFE), Merck & Company Inc. (NYSE: MRK), AstraZeneca PLC (NASDAQ: AZN) and Novartis AG (NYSE: NVS) — all aiming to capitalize on what may be the next blockbuster and defend hundreds of millions from a silent killer.

Greenland Technologies Holding Corporation (NASDAQ: GTEC), a technology developer and manufacturer of electric industrial vehicles and drivetrain systems for material handling machineries and vehicles, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers the Company's recent announcement of availability of its latest electric industrial vehicle, the GEL-5000, under its new clean industrial heavy equipment brand, HEVI. To hear the audio production, visit: https://www.nnw.fm/DZAG7  To read the original press release, visit: https://nnw.fm/qSskN The new GEL-5000 is a 5.0-ton rated load all-electric lithium wheeled front loader that boasts strong power, approximately 40,000 pounds operating weight and increased payload options, making it a clean, green industrial vehicle with a rapid two-hour charge time and nine hours of operation time per charge. 

Greenland Technologies Holding Corporation (NASDAQ: GTEC), a technology developer and manufacturer of electric industrial vehicles and drivetrain systems for material handling machineries and vehicles, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers the Company's recent announcement of availability of its latest electric industrial vehicle, the GEL-5000, under its new clean industrial heavy equipment brand, HEVI. To hear the audio production, visit: https://www.nnw.fm/DZAG7  To read the original press release, visit: https://nnw.fm/qSskN The new GEL-5000 is a 5.0-ton rated load all-electric lithium wheeled front loader that boasts strong power, approximately 40,000 pounds operating weight and increased payload options, making it a clean, green industrial vehicle with a rapid two-hour charge time and nine hours of operation time per charge. 

The world may be on the cusp of a new generation of computing. Its name? Quantum computing. Much like its precursors, quantum computing doesn't have a sole inventor or a single brand; it is the collective product of decades of work by many of the brightest minds in science and technology. The nascent industry is highly complex employing varied approaches to harness the power of quantum mechanics to solve challenges that classic computers simply cannot handle. A paradigm shift of computing may be coming, and it would have a far-reaching impact. Currently real, practical quantum computing applications are helping solve a myriad of business challenges. Hundreds of early quantum applications have been built attempting to address resource scheduling, mobility, logistics, drug-discovery, portfolio optimization and manufacturing processes. The world's first commercial supplier of quantum computers, D-Wave Systems Inc. (“D-Wave”) is a leader in the development and delivery of quantum computing systems, software, and services and is the only company building both annealing quantum computers and gate-model quantum computers. D-Wave's customers include more than two dozen of the Forbes Global 2000 companies, including Volkswagen, Accenture, NEC Corporation and Lockheed Martin. Of major interest is that D-Wave is working to complete a business combination transaction (Business Combination) with blank-check company DPCM Capital Inc. (NYSE: XPOA) (DPCM Capital Profile) to bring it public. In geekdom, D-Wave is already a household name, but as a public company, it is expected to gain even greater recognition for its products and services by helping to bring quantum computing into the mainstream. Other companies, such as Microsoft Corporation (NASDAQ: MSFT), Alphabet Inc. (NASDAQ: GOOGL), International Business Machines Corporation (NYSE: IBM) and Honeywell International Inc. (NASDAQ: HON), are also seeking to make significant contributions to quantum computing.

The world may be on the cusp of a new generation of computing. Its name? Quantum computing. Much like its precursors, quantum computing doesn't have a sole inventor or a single brand; it is the collective product of decades of work by many of the brightest minds in science and technology. The nascent industry is highly complex employing varied approaches to harness the power of quantum mechanics to solve challenges that classic computers simply cannot handle. A paradigm shift of computing may be coming, and it would have a far-reaching impact. Currently real, practical quantum computing applications are helping solve a myriad of business challenges. Hundreds of early quantum applications have been built attempting to address resource scheduling, mobility, logistics, drug-discovery, portfolio optimization and manufacturing processes. The world's first commercial supplier of quantum computers, D-Wave Systems Inc. (“D-Wave”) is a leader in the development and delivery of quantum computing systems, software, and services and is the only company building both annealing quantum computers and gate-model quantum computers. D-Wave's customers include more than two dozen of the Forbes Global 2000 companies, including Volkswagen, Accenture, NEC Corporation and Lockheed Martin. Of major interest is that D-Wave is working to complete a business combination transaction (Business Combination) with blank-check company DPCM Capital Inc. (NYSE: XPOA) (DPCM Capital Profile) to bring it public. In geekdom, D-Wave is already a household name, but as a public company, it is expected to gain even greater recognition for its products and services by helping to bring quantum computing into the mainstream. Other companies, such as Microsoft Corporation (NASDAQ: MSFT), Alphabet Inc. (NASDAQ: GOOGL), International Business Machines Corporation (NYSE: IBM) and Honeywell International Inc. (NASDAQ: HON), are also seeking to make significant contributions to quantum computing.

Listing follows the successful launch of the Company's commercial-scale AI turnkey SaaS in-real-time knowledge engine called ‘Pluaris.' Pluaris solves the information overload problem commonly experienced at work and at home. The Company believes the personal knowledge management (KM) market opportunity has over 1 billion users and is currently underserved. NOWG begins trading today. Nowigence, Inc. (OTCQB: NOWG) announces today that its common stock will begin trading on the OTCQB Venture Market, the mid-tier OTC equity market, which lists primarily early-stage and developing companies in the U.S. and international markets. To view the full press release, visit https://nnw.fm/GD8g6

Listing follows the successful launch of the Company's commercial-scale AI turnkey SaaS in-real-time knowledge engine called ‘Pluaris.' Pluaris solves the information overload problem commonly experienced at work and at home. The Company believes the personal knowledge management (KM) market opportunity has over 1 billion users and is currently underserved. NOWG begins trading today. Nowigence, Inc. (OTCQB: NOWG) announces today that its common stock will begin trading on the OTCQB Venture Market, the mid-tier OTC equity market, which lists primarily early-stage and developing companies in the U.S. and international markets. To view the full press release, visit https://nnw.fm/GD8g6

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF), Canada's renewable natural gas (“RNG”) infrastructure platform, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers EverGen's recent announcement of its entry into definitive agreements with Northeast Renewables LP (“Northeast”) to acquire a 50% interest in a portfolio of RNG development projects. To read the original press release, visit: https://nnw.fm/PRohG As detailed in the news release, Project Radius, located in southern Ontario, is a late-development-stage portfolio of three high-quality, on-farm RNG projects, collectively capable of producing roughly 1.7 million GJ/year of RNG that will contribute to the reduction of emissions from agricultural operations in southern Ontario. Each of the three projects is expected to produce approximately 550,000 GJ/year and will be constructed throughout 2023 and 2024. “The acquisition of Project Radius provides a foothold in Ontario - a new and strategic jurisdiction in which EverGen can continue to participate in the consolidation and growth of the RNG industry in the near-term, as well as benefit from project economics in line with or exceeding those we have seen with our initial projects,” Chase Edgelow, CEO of EverGen, stated in the news release. “Working alongside Northeast to advance the projects, EverGen will deliver on our platform expansion commitments with the potential to exceed 1,000,000 GJ of RNG production annually. Ontario has an abundant amount of excess organic feedstock, and as a leader in the RNG industry, EverGen can develop the sustainable infrastructure that contributes to carbon-negative energy production and the greening of the province.”

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF), Canada's renewable natural gas (“RNG”) infrastructure platform, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers EverGen's recent announcement of its entry into definitive agreements with Northeast Renewables LP (“Northeast”) to acquire a 50% interest in a portfolio of RNG development projects. To read the original press release, visit: https://nnw.fm/PRohG As detailed in the news release, Project Radius, located in southern Ontario, is a late-development-stage portfolio of three high-quality, on-farm RNG projects, collectively capable of producing roughly 1.7 million GJ/year of RNG that will contribute to the reduction of emissions from agricultural operations in southern Ontario. Each of the three projects is expected to produce approximately 550,000 GJ/year and will be constructed throughout 2023 and 2024. “The acquisition of Project Radius provides a foothold in Ontario - a new and strategic jurisdiction in which EverGen can continue to participate in the consolidation and growth of the RNG industry in the near-term, as well as benefit from project economics in line with or exceeding those we have seen with our initial projects,” Chase Edgelow, CEO of EverGen, stated in the news release. “Working alongside Northeast to advance the projects, EverGen will deliver on our platform expansion commitments with the potential to exceed 1,000,000 GJ of RNG production annually. Ontario has an abundant amount of excess organic feedstock, and as a leader in the RNG industry, EverGen can develop the sustainable infrastructure that contributes to carbon-negative energy production and the greening of the province.”

Seems like yesterday people were smoking cigarettes everywhere; many people still have memories of Grandpa puffing on his Camels. It wasn't until 1993 that smoking was banned in hospitals and on airplanes in 1998. Despite these and many other restrictions, the global market for nicotine-based products remains incredibly robust. Total global retail sales associated with the nicotine ecosystem during 2020 reached approximately $853 billion with around 5.2 trillion retail cigarette sticks sold. Nicotine isn't just big business, it's huge business, and companies are constantly looking for ways to keep and grow market share. The majors are evermore turning to innovation and alternative delivery methods to achieve their objectives. An example of that is the breakthrough technology of Lexaria Bioscience Corp. (NASDAQ: LEXX) (Profile) and its patented DehydraTECH(TM) delivery platform. Suitable for use across a wide range of product formats such as pharmaceuticals, nutraceuticals and over-the-counter products, Lexaria's DehydraTECH also increases the delivery characteristics of orally administered nicotine.

Seems like yesterday people were smoking cigarettes everywhere; many people still have memories of Grandpa puffing on his Camels. It wasn't until 1993 that smoking was banned in hospitals and on airplanes in 1998. Despite these and many other restrictions, the global market for nicotine-based products remains incredibly robust. Total global retail sales associated with the nicotine ecosystem during 2020 reached approximately $853 billion with around 5.2 trillion retail cigarette sticks sold. Nicotine isn't just big business, it's huge business, and companies are constantly looking for ways to keep and grow market share. The majors are evermore turning to innovation and alternative delivery methods to achieve their objectives. An example of that is the breakthrough technology of Lexaria Bioscience Corp. (NASDAQ: LEXX) (Profile) and its patented DehydraTECH(TM) delivery platform. Suitable for use across a wide range of product formats such as pharmaceuticals, nutraceuticals and over-the-counter products, Lexaria's DehydraTECH also increases the delivery characteristics of orally administered nicotine.

It's generally accepted that the phrase “Internet of Things” was coined in 1999 during a presentation for Procter & Gamble. Actually, the concept was already in use more than 15 years earlier when programmers at Carnegie Mellon University connected a Coke machine to the internet so they could see if there were any cold Cokes available before walking to the machine to buy one. After four decades, the Internet of Things (“IoT”) has become ubiquitous, making its way into essentially every facet of day-to-day life and consumer demand for IoT products has become insatiable. That demand has proved a boon for innovative companies such as SPYR Inc. (OTCQB: SPYR) (Profile) as well as famous FAANG companies: Apple Inc. (NASDAQ: AAPL), Amazon.com Inc. (NASDAQ: AMZN), Google (NASDAQ: GOOG) and Meta Platforms Inc. (NASDAQ: FB) (formerly known as Facebook).

It's generally accepted that the phrase “Internet of Things” was coined in 1999 during a presentation for Procter & Gamble. Actually, the concept was already in use more than 15 years earlier when programmers at Carnegie Mellon University connected a Coke machine to the internet so they could see if there were any cold Cokes available before walking to the machine to buy one. After four decades, the Internet of Things (“IoT”) has become ubiquitous, making its way into essentially every facet of day-to-day life and consumer demand for IoT products has become insatiable. That demand has proved a boon for innovative companies such as SPYR Inc. (OTCQB: SPYR) (Profile) as well as famous FAANG companies: Apple Inc. (NASDAQ: AAPL), Amazon.com Inc. (NASDAQ: AMZN), Google (NASDAQ: GOOG) and Meta Platforms Inc. (NASDAQ: FB) (formerly known as Facebook).

Every gambler is on the lookout for a lock, but as every gambler knows, the only sure way to double your money is to fold it over and tuck it in your pocket. Humanity's penchant for gambling traces back to state-run lottos in 200 BC China to the first U.S. online lotto in 1994 and now proliferates across the globe on PCs and mobile devices. Transacted through internet platforms, online gaming (or internet gambling) offers inventive games of chance as well as virtual poker and sports betting. The online gaming market is booming, eclipsing $70 billion last year, and all manner of casinos and upstart platforms are scrambling for a piece of the action. As lucrative as this all sounds there's an Achilles heel for these platforms: customer acquisition cost vs. customer lifetime value. In the United States, the customer acquisition cost for an online casino player is more than $500,  and some estimate player value at $300 or less. The math simply doesn't work, and some online casino operators have come to realize that traditional advertising for sports betting and iGaming products presents an irrational cost of customer acquisition. With the online gaming market expected to explode to more than $130 billion in the next five years, there may be a smarter way to cash in on the action. Much like the merchants that made millions during the gold boom while prospectors panned for dreams, providing B2B services such as online gaming platforms, systems and gaming content has proved to be a winning business model. Coming off its 14th consecutive quarter of profitability, Golden Matrix Group Inc. (NASDAQ: GMGI) (Profile) continues to carve out enviable market share by delivering state-of-the-art configurable and scalable white-label B2B gaming platforms for its customers across the globe. Golden Matrix's gaming IP includes sophisticated tools for marketing, acquisition, retention and monetization of users — exactly what iGaming operators need. With more than 580 unique casino operations, 30-plus partnerships, 6 million-plus end users and 3,161 original games, Golden Matrix has established itself as one of the world's leading providers of turnkey and white-label gaming platforms, Esports technology and gaming content, and the company has even bigger plans for market dominion. All the major casino operators, including Caesars Entertainment Inc. (NASDAQ: CZR), Penn National Gaming Inc. (NASDAQ: PENN), MGM Resorts International (NYSE: MGM) and Las Vegas Sands Corp. (NYSE: LVS) are trying to entice users to download their apps as they fight for a piece of the online action and struggle with customer acquisition costs.

Every gambler is on the lookout for a lock, but as every gambler knows, the only sure way to double your money is to fold it over and tuck it in your pocket. Humanity's penchant for gambling traces back to state-run lottos in 200 BC China to the first U.S. online lotto in 1994 and now proliferates across the globe on PCs and mobile devices. Transacted through internet platforms, online gaming (or internet gambling) offers inventive games of chance as well as virtual poker and sports betting. The online gaming market is booming, eclipsing $70 billion last year, and all manner of casinos and upstart platforms are scrambling for a piece of the action. As lucrative as this all sounds there's an Achilles heel for these platforms: customer acquisition cost vs. customer lifetime value. In the United States, the customer acquisition cost for an online casino player is more than $500,  and some estimate player value at $300 or less. The math simply doesn't work, and some online casino operators have come to realize that traditional advertising for sports betting and iGaming products presents an irrational cost of customer acquisition. With the online gaming market expected to explode to more than $130 billion in the next five years, there may be a smarter way to cash in on the action. Much like the merchants that made millions during the gold boom while prospectors panned for dreams, providing B2B services such as online gaming platforms, systems and gaming content has proved to be a winning business model. Coming off its 14th consecutive quarter of profitability, Golden Matrix Group Inc. (NASDAQ: GMGI) (Profile) continues to carve out enviable market share by delivering state-of-the-art configurable and scalable white-label B2B gaming platforms for its customers across the globe. Golden Matrix's gaming IP includes sophisticated tools for marketing, acquisition, retention and monetization of users — exactly what iGaming operators need. With more than 580 unique casino operations, 30-plus partnerships, 6 million-plus end users and 3,161 original games, Golden Matrix has established itself as one of the world's leading providers of turnkey and white-label gaming platforms, Esports technology and gaming content, and the company has even bigger plans for market dominion. All the major casino operators, including Caesars Entertainment Inc. (NASDAQ: CZR), Penn National Gaming Inc. (NASDAQ: PENN), MGM Resorts International (NYSE: MGM) and Las Vegas Sands Corp. (NYSE: LVS) are trying to entice users to download their apps as they fight for a piece of the online action and struggle with customer acquisition costs.

The Internet of Things (“IoT”) is easily one of the most powerful emerging technologies in the world today. As the IoT market for smart homes and connected cars (smart cars) continues on its path of parabolic growth, it's clear that IoT presents historic opportunities. Today's homes are increasingly connected, creating an enormous new smart-home market, and the smart-car market segment has become a nearly ubiquitous strategic development path for the auto industry as demand for constant connectivity soars. With functionality and convenience, SPYR Inc. (OTCQB: SPYR) (Profile) is delivering to consumers what they crave — smart hardware, software solutions and products that integrate with the Apple Inc. (NASDAQ: AAPL) ecosystem. Apple commands the largest share in the mobile devices market and will likely be dominant as the IoT market expands and consumers demand more privacy protection. Other tech juggernauts such as Amazon.com Inc. (NASDAQ: AMZN), Google (NASDAQ: GOOG), and Meta Platforms Inc. (NASDAQ: FB) (formerly Facebook) are also working on next-generation devices and control centers for fully connected cars and homes.

The Internet of Things (“IoT”) is easily one of the most powerful emerging technologies in the world today. As the IoT market for smart homes and connected cars (smart cars) continues on its path of parabolic growth, it's clear that IoT presents historic opportunities. Today's homes are increasingly connected, creating an enormous new smart-home market, and the smart-car market segment has become a nearly ubiquitous strategic development path for the auto industry as demand for constant connectivity soars. With functionality and convenience, SPYR Inc. (OTCQB: SPYR) (Profile) is delivering to consumers what they crave — smart hardware, software solutions and products that integrate with the Apple Inc. (NASDAQ: AAPL) ecosystem. Apple commands the largest share in the mobile devices market and will likely be dominant as the IoT market expands and consumers demand more privacy protection. Other tech juggernauts such as Amazon.com Inc. (NASDAQ: AMZN), Google (NASDAQ: GOOG), and Meta Platforms Inc. (NASDAQ: FB) (formerly Facebook) are also working on next-generation devices and control centers for fully connected cars and homes.

The Internet of Things (“IoT”) has evolved over the last couple decades, weaving its way into daily life by providing increased utility and functionality for everyday items. Broadly speaking, IoT refers to the overarching technology that connects physical items (e.g., refrigerators, door locks, HVAC) to the internet so they can be controlled from a mobile or desktop app to provide real-time controls and data analysis. Delivering convenience and savings, many of these interconnected devices have become readily available and affordable with an estimated 46 billion connected devices in the world today. That may sound like a lot, but the nascent market is quickly expanding, creating plenty of opportunity for innovative companies such as SPYR Inc. (OTCQB: SPYR) (Profile) to capture market share by leveraging the platforms of tech giants such as Apple Inc. (NASDAQ: AAPL), Microsoft Corporation (NASDAQ: MSFT), Amazon.com Inc. (NASDAQ: AMZN) and Intel Corporation (NASDAQ: INTC), which will all continue to benefit from an interconnected global economy booming with connected devices.